Fig. 7
From: The adverse effects of chemotherapy on bone mass are not prevented by senolytics
Low bone mass persists up to twelve months after cessation of TAC. (a) Schematic of experimental design created with BioRender.com. Quantitative μCT analysis of femur (b) cortical thickness at midshaft (left), and trabecular bone volume over tissue volume (BV/TV) at the distal end (right); (c) fifth lumbar vertebrae BV/TV, and (d) trabecular microarchitecture. Data represents mean ± SD; p-values using two-way ANOVA followed by Tukey’s multiple comparisons test for (b, left) and (d). Kruskal–Wallis with Dunn’s correction for (b, right) and (c). The most relevant comparisons between individual groups are displayed.
